Free Trial

Lipocine (LPCN) SEC Filings & 10K Form

Lipocine logo
$3.30 0.00 (0.00%)
Closing price 06/11/2025 03:59 PM Eastern
Extended Trading
$3.32 +0.03 (+0.76%)
As of 06/11/2025 06:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Lipocine SEC Filings

DateFilerForm TypeView
06/09/2025
5:13 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2025
3:05 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2025
4:31 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
8:30 AM
Lipocine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2025
8:30 AM
Lipocine (Filer)
Form DEF 14A
04/10/2025
3:05 PM
Lipocine (Filer)
Form PRE 14A
04/03/2025
3:31 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
8:45 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
8:30 AM
Lipocine (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2025
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:00 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
5:04 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
6:46 PM
Lipocine (Issuer)
Patel Mahesh V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
6:47 PM
Lipocine (Issuer)
Patel Mahesh V. (Reporting)
Form 4/A
12/30/2024
7:03 PM
Fogarty Krista (Reporting)
Lipocine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
7:04 PM
Lipocine (Issuer)
Patel Mahesh V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
5:06 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
8:45 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
5:09 AM
Lipocine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
3:37 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:05 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
5:04 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
8:39 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
10:23 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
5:19 AM
Lipocine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
5:20 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
7:15 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
7:15 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LPCN) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners